Fortress Biotech
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $16,413 | $13,139 | $15,120 | $14,629 |
Gross Profit | 11,474 | 8,349 | 12,883 | 9,344 |
EBITDA | -8,424 | -20,990 | -21,444 | -21,066 |
EBIT | -9,580 | -22,181 | -20,203 | -24,389 |
Net Income | 15,486 | -10,584 | -6,765 | -12,867 |
Net Change In Cash | 16,413 | 13,139 | 15,120 | 14,629 |
Free Cash Flow | -27,560 | -19,563 | -12,907 | -20,059 |
Cash | 74,386 | 91,339 | 57,263 | 58,853 |
Basic Shares | 29,824 | 26,450 | 20,240 | 19,697 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $57,675 | $84,513 | $75,743 | $68,791 |
Gross Profit | 36,796 | 61,620 | 44,968 | 36,707 |
EBITDA | -104,491 | -135,721 | -190,469 | -146,168 |
EBIT | -108,955 | -141,718 | -199,822 | -152,959 |
Net Income | -45,997 | -60,637 | -86,575 | -64,703 |
Net Change In Cash | 57,675 | 84,513 | 75,743 | 68,791 |
Cost of Revenue | 72,968 | |||
Free Cash Flow | -95,191 | -136,323 | -182,456 | -132,886 |
Cash | 57,263 | 80,927 | 178,266 | 305,744 |
Basic Shares | 20,784 | 8,111 | 5,925 | 5,447 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | $0.45 |
2025-03-31 | -$0.48 |
2024-12-31 | -$0.29 |
2024-09-30 | -$0.76 |
